David Hovland

Consigliere Generale presso ELEDON PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profilo

David Hovland is currently the Chief Regulatory Officer at Eledon Pharmaceuticals, Inc. Prior to this, he was the Senior Vice President-Global Regulatory Affairs at Urovant Sciences Ltd.
from 2018 to 2021.
He was also the Vice President-Global Regulatory Affairs at Allergan Ltd.
(Ireland) from 2015 to 2018.
Before that, he was the Director-Global Regulatory Affairs at Amgen, Inc. from 2006 to 2010.
He started his career as a Study Director at Allergan Ltd.
(Ireland) from 1999 to 2002.
Dr. Hovland holds a doctorate degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Berkeley.

Posizioni attive di David Hovland

Società	Posizione	Inizio
ELEDON PHARMACEUTICALS, INC.	Consigliere Generale	19/04/2021

Tutte le posizioni attive di David Hovland

Precedenti posizioni note di David Hovland

Società	Posizione	Fine
UROVANT SCIENCES LTD.	Consigliere Generale	01/04/2021
ALLERGAN PLC	Consigliere Generale	01/01/2018
AMGEN INC.	Consigliere Generale	01/01/2010
ALLERGAN PLC	Corporate Officer/Principal	01/01/2002

Vedi nel dettaglio l'esperienza di David Hovland

Formazione di David Hovland

University of California, Los Angeles	Doctorate Degree
University of California, Berkeley	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David Hovland

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
AMGEN INC.	Health Technology
ELEDON PHARMACEUTICALS, INC.	Health Technology

Aziende private	2
Urovant Sciences Ltd. Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom.	Health Technology
Allergan Ltd. (Ireland) Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland.	Health Technology

Aziende private